Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Doxorubicin × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 42 Breast Neoplasms 30 Lymphoma 29 Sarcoma 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Hodgkin Disease 22 Triple Negative Breast Neoplasms 21 Burkitt Lymphoma 21 Ovarian Neoplasms 15 Neoplasms 15 Lymphoma, Follicular 15 Lymphoma, B-Cell 13 Lymphoma, Non-Hodgkin 12 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, T-Cell, Peripheral 9 Neoplasm Metastasis 8 Lymphoma, Mantle-Cell 8 Liposarcoma 8 Fallopian Tube Neoplasms 8 Endometrial Neoplasms 8 Recurrence 7 Neuroblastoma 7 Leiomyosarcoma 7 Multiple Myeloma 6 Lymphoma, B-Cell, Marginal Zone 6 Leukemia 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Osteosarcoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Inflammatory Breast Neoplasms 5

Interventions

Cyclophosphamide 6 Vincristine 3 Temozolomide 3 Radiotherapy 3 Cisplatin 3 Automobiles 3 fludarabine 2 Etoposide 2 Eflornithine 2 Carboplatin 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 etoposide phosphate 1 belzutifan 1 Zoledronic Acid 1 Thiotepa 1 Tamoxifen 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Mesna 1 Maintenance Chemotherapy 1 Lomustine 1 Isotretinoin 1 Infusions, Intravenous 1 Induction Chemotherapy 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡